Amplifon SpA (AMFPF)
12.01
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Amplifon EPS Diluted (Quarterly) : 0.0544 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.0544 |
| December 31, 2025 | 0.0869 |
| September 30, 2025 | 0.0325 |
| June 30, 2025 | 0.1764 |
| March 31, 2025 | 0.1529 |
| December 31, 2024 | 0.1949 |
| September 30, 2024 | 0.0793 |
| June 30, 2024 | 0.2498 |
| March 31, 2024 | 0.1665 |
| December 31, 2023 | 0.2463 |
| September 30, 2023 | 0.1065 |
| June 30, 2023 | 0.2506 |
| March 31, 2023 | 0.139 |
| December 31, 2022 | 0.2835 |
| September 30, 2022 | 0.1309 |
| June 30, 2022 | 0.261 |
| March 31, 2022 | 0.1515 |
| December 31, 2021 | 0.2868 |
| September 30, 2021 | 0.1223 |
| June 30, 2021 | 0.2856 |
| March 31, 2021 | 0.1234 |
| December 31, 2020 | 0.3145 |
| September 30, 2020 | 0.1474 |
| June 30, 2020 | 0.0363 |
| March 31, 2020 | 0.025 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.2332 |
| September 30, 2019 | 0.0348 |
| June 30, 2019 | 0.183 |
| March 31, 2019 | 0.0897 |
| December 31, 2018 | 0.2176 |
| September 30, 2018 | 0.055 |
| June 30, 2018 | 0.1724 |
| March 31, 2018 | 0.0802 |
| December 31, 2017 | 0.2749 |
| September 30, 2017 | 0.0527 |
| June 30, 2017 | 0.1238 |
| March 31, 2017 | 0.0608 |
| December 31, 2016 | 0.1163 |
| September 30, 2016 | 0.0481 |
| June 30, 2016 | 0.1056 |
| March 31, 2016 | 0.042 |
| December 31, 2015 | 0.1046 |
| September 30, 2015 | 0.0332 |
| June 30, 2015 | 0.0738 |
| March 31, 2015 | 0.0179 |
| December 31, 2014 | 0.1137 |
| September 30, 2014 | 0.0209 |
| June 30, 2014 | 0.0768 |
| March 31, 2014 | 0.0614 |
| December 31, 2013 | 0.0861 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Interpace Biosciences, Inc. | 0.026 |
| Medical Marijuana, Inc. | -0.0001 |
| DiaSorin SpA | -- |
| Akso Health Group | -- |
| Acro Biomedical Co. Ltd. | -0.0007 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 12.37M |
| Revenue (Quarterly) | 678.28M |
| Total Expenses (Quarterly) | 665.97M |
| Enterprise Value | 4.354B |
| Gross Profit Margin (Quarterly) | 11.02% |
| Profit Margin (Quarterly) | 1.82% |
| Earnings Yield | 2.92% |
| Operating Earnings Yield | 8.93% |
| Normalized Earnings Yield | 3.388 |